#cardiovascular

Chronic obstructive pulmonary disease is an umbrella term for various progressive lung diseases, including emphysema.

That’s according to a systematic review and meta-analysis of dozens of studies including 125,000 people.

Researchers have for the first time properly assessed HIV’s association with this health outcome.

That’s compared with using patches, gum, lozenges, sprays, inhalers or a combination of such products.

HIV-positive individuals tend to develop frailty at a younger age than the general population.

Researchers analyzed health data from 2004 and 2014 regarding a cohort of people with HIV who initially had a median age of 41.

More research is needed to determine the potential risks and benefits of testosterone treatment in this population.

Statins are currently under investigation as a preventive for inflammation-related health problems in people with HIV.

That’s according to an analysis of HIV-positive people released from jail or prison in Connecticut.

A research team has sought to address the critical lack of treatment guidelines for addressing HIV’s complex effects on aging.

Living with chronic pain not only drags down quality of life, but it is also linked to poorer HIV-related health outcomes.

A new analysis of a massive amount of global data reached a conclusion similar to that of previous research.

This increased risk is not driven by differences in plaque buildup in the arteries compared with those who are HIV negative.

This connection remained even when researchers took into account various risk factors for cardiovascular disease.

A recent meta-analysis compared side effects linked to Tivicay versus other antiretrovirals.

A recent study found that factors other than coronary plaque likely drive this sex-based difference.